Trial site
NZOZ Lecznica MAK MED S C
- 12running trials
- 19closed trials
The trials here
What the 32 trials at this site are about, from their registry records.
- Conditions
- Psoriasis12 trials
- Psoriatic arthritis11 trials
- Rheumatoid arthritis8 trials
- Lupus (SLE)5 trials
- Osteoarthritis2 trials
- Ankylosing spondylitis1 trial
- Giant cell arteritis1 trial
- Obesity1 trial
- Sjögren's disease1 trial
- Phase
- Phase 317 trials
- Phase 210 trials
- Phase 43 trials
- Phase 12 trials
- Status
- Completed18 trials
- Active, not recruiting8 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC10 trials
- MoonLake Immunotherapeutics AG3 trials
- Celltrion Inc.2 trials
- IGM Biosciences Inc.2 trials
- Takeda2 trials
- and 13 more
Running trials
Not yet recruiting
Recruiting
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Not yet recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Phase 2 Placebo-controlled Study to Assess the Safety, Efficacy, and PK of ESK-001 in SLE
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)2 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Active, not recruiting
Recruiting
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
Completed
Completed
Completed
Completed
Completed
Completed
A Phase 1b Study of Imvotamab in Severe Systemic Lupus Erythematosus
Completed
A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis
Completed
Completed
Completed
Completed
Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis
Completed
Completed
Completed
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
Terminated
Completed
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Site data: ClinicalTrials.govUpdated 18 Nov 2026